Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Should I Take Aspirin? (SITA): RCT of a decision aid for cancer chemoprevention.
Onwuka SR, Boyd L, Wijesuriya R, Broun K, Marker J, Shub M, McIntosh JG, Macrae F, Chondros P, Saya S, Novy K, Jenkins MA, Walter FM, Trevena L, Martinez Gutierrez J, Fishman G, Emery J. Onwuka SR, et al. Among authors: chondros p. Br J Gen Pract. 2024 Mar 25:BJGP.2023.0385. doi: 10.3399/BJGP.2023.0385. Online ahead of print. Br J Gen Pract. 2024. PMID: 38527793
An RCT of a decision aid to support informed choices about taking aspirin to prevent colorectal cancer and other chronic diseases: a study protocol for the SITA (Should I Take Aspirin?) trial.
Milton S, McIntosh J, Macrae F, Chondros P, Trevena L, Jenkins M, Walter FM, Taylor N, Boyd L, Saya S, Karnchanachari N, Novy K, Forbes C, Gutierrez JM, Broun K, Whitburn S, McGill S, Fishman G, Marker J, Shub M, Emery J. Milton S, et al. Among authors: chondros p. Trials. 2021 Jul 15;22(1):452. doi: 10.1186/s13063-021-05365-8. Trials. 2021. PMID: 34266464 Free PMC article.
The Colorectal cancer RISk Prediction (CRISP) trial: a randomised controlled trial of a decision support tool for risk-stratified colorectal cancer screening.
Emery JD, Jenkins MA, Saya S, Chondros P, Oberoi J, Milton S, Novy K, Habgood E, Karnchanachari N, Pirotta M, Trevena L, Bickerstaffe A, De Abreu Lourenço R, Crothers A, Ouakrim DA, Flander L, Dowty JG, Walter FM, Clark M, Doncovio S, Etemadmoghadam D, Fishman G, Macrae F, Winship I, McIntosh JG. Emery JD, et al. Among authors: chondros p. Br J Gen Pract. 2023 Jul 27;73(733):e556-e565. doi: 10.3399/BJGP.2022.0480. Print 2023 Aug. Br J Gen Pract. 2023. PMID: 37012077 Free PMC article. Clinical Trial.
The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial.
Walker JG, Macrae F, Winship I, Oberoi J, Saya S, Milton S, Bickerstaffe A, Dowty JG, De Abreu Lourenço R, Clark M, Galloway L, Fishman G, Walter FM, Flander L, Chondros P, Ait Ouakrim D, Pirotta M, Trevena L, Jenkins MA, Emery JD. Walker JG, et al. Among authors: chondros p. Trials. 2018 Jul 25;19(1):397. doi: 10.1186/s13063-018-2764-7. Trials. 2018. PMID: 30045764 Free PMC article.
The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary care.
Saya S, Boyd L, Chondros P, McNamara M, King M, Milton S, Lourenco RA, Clark M, Fishman G, Marker J, Ostroff C, Allman R, Walter FM, Buchanan D, Winship I, McIntosh J, Macrae F, Jenkins M, Emery J. Saya S, et al. Among authors: chondros p. Trials. 2022 Sep 27;23(1):810. doi: 10.1186/s13063-022-06734-7. Trials. 2022. PMID: 36163034 Free PMC article.
The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program.
Wood A, Emery JD, Jenkins M, Chondros P, Campbell T, Wenkart E, O'Reilly C, Cowie T, Dixon I, Toner J, Khalajzadeh H, Gutierrez JM, Govan L, Buckle G, McIntosh JG. Wood A, et al. Among authors: chondros p. Trials. 2022 Jan 12;23(1):31. doi: 10.1186/s13063-021-05877-3. Trials. 2022. PMID: 35022080 Free PMC article. Clinical Trial.
SMARTERscreen protocol: a three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian National Bowel Cancer Screening Program.
McIntosh JG, Emery JD, Wood A, Chondros P, Goodwin BC, Trevena J, Wilson C, Chang S, Hocking J, Campbell T, Macrae F, Milley K, Lew JB, Nightingale C, Dixon I, Castelli M, Lee N, Innes L, Jolley T, Fletcher S, Buchanan L, Doncovio S, Broun K, Austin G, Jiang J, Jenkins MA. McIntosh JG, et al. Among authors: chondros p. Trials. 2023 Nov 13;24(1):723. doi: 10.1186/s13063-023-07756-5. Trials. 2023. PMID: 37957680 Free PMC article.
The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care.
Saya S, Chondros P, Abela A, Mihalopolous C, Chatterton ML, Gunn J, Chen TF, Polasek TM, Dettmann E, Brooks R, King M, Spencer L, Alphonse P, Milton S, Ramsay G, Siviour Z, Liew J, Ly P, Thoenig M, Seychell R, La Rocca F, Hesson LB, Mejias N, Sivertsen T, Galea MA, Bousman C, Emery J. Saya S, et al. Among authors: chondros p. Trials. 2023 May 19;24(1):342. doi: 10.1186/s13063-023-07361-6. Trials. 2023. PMID: 37208772 Free PMC article.
97 results